Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial (Q102318823)
Jump to navigation
Jump to search
scientific article published on 18 November 2020
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial |
scientific article published on 18 November 2020 |
Statements
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial (English)
Merryn Voysey
Adrian V S Hill
Andrew J Pollard
Tonya L Villafana
Katie J Ewer
Katherine R W Emary
Amy L Flaxman
Alison M Lawrie
Teresa Lambe
Sarah C Gilbert
Emma Plested
Matthew D Snape
Elizabeth A Clutterbuck
Daniel R Owens
1 reference
Brian Angus
Pedro M Folegatti
Alexander D Douglas
Simon Kerridge
Parvinder K Aley
Sandra Belij-Rammerstorfer
Sagida Bibi
Christina Dold
Bassam Hallis
Rebecca Makinson
Oxford COVID Vaccine Trial Group
Angela M Minassian
Paola Cicconi
Rachel Colin-Jones
Alice Lelliott
Natalie G Marchevsky
Yama Mujadidi
Sarah Rhead
Rinn Song
Marion E E Watson
Maheshi N Ramasamy
Gavin Babbage
Lisa Berry
Mustapha Bittaye
Katrina Cathie
Harry Chappell
Sue Charlton
Sofiyah Fedosyuk
Michelle Fuskova
Diane Gbesemete
Catherine Green
Mimi M Hou
Daniel Jenkin
Elizabeth J Kelly
May N Lwin
Alasdair P S Munro
Mihaela Pacurar
Jade Rand
Thomas Rawlinson
Hannah Robinson
Adam J Ritchie
Amy L Ross-Russell
Stephen Saich
Nisha Singh
Catherine C Smith
Richard Tarrant
Yrene Themistocleous
Kelly M Thomas
Sarah C Warren
18 November 2020